These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10956321)

  • 1. Benefits of once-daily therapies in the treatment of hypertension.
    Flack JM; Nasser SA
    Vasc Health Risk Manag; 2011; 7():777-87. PubMed ID: 22241952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension.
    Meredith PA
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i39-41; discussion i50. PubMed ID: 10956321
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 5. AT(1) receptor antagonists-beyond blood pressure control: possible place in heart failure treatment.
    McMurray J
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i42-5: discussion i50. PubMed ID: 10956322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison with other antihypertensive drugs, especially with ACEI].
    Hiwada K
    Nihon Rinsho; 1999 May; 57(5):1187-93. PubMed ID: 10361454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin I receptor blockers for heart failure].
    Fruhwald FM; Kickenweiz E; Zweiker R; Klein W
    Wien Med Wochenschr; 2001; 151(7-8):157-9. PubMed ID: 11450163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
    Diamant M; Vincent HH
    J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan.
    Andersson OK; Neldam S
    Blood Press; 1998 Jan; 7(1):53-9. PubMed ID: 9551878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.
    Heuer HJ; Schöndorfer G; Högemann AM
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S55-6. PubMed ID: 9331008
    [No Abstract]   [Full Text] [Related]  

  • 12. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.
    Mancia G; Zanchetti A; Agabiti-Rosei E; Benemio G; De Cesaris R; Fogari R; Pessina A; Porcellati C; Rappelli A; Salvetti A; Trimarco B
    Circulation; 1997 Mar; 95(6):1464-70. PubMed ID: 9118514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-pressure control in the hypertensive population.
    Mancia G; Sega R; Milesi C; Cesana G; Zanchetti A
    Lancet; 1997 Feb; 349(9050):454-7. PubMed ID: 9040574
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.